Oral and intestinal Candida colonization in patients undergoing hematopoietic stem-cell transplantation

Journal of Infectious Diseases

Volumn 198, Issue 1, 2008, Pages 150-153

  Zollner Schwetz, Ines ^a   Auner, Holger W ^a,c   Paulitsch, Astrid ^a   Buzina, Walter ^a   Staber, Philipp B ^a   Ofner Kopeinig, Petra ^a   Reisinger, Emil C ^b   Olschewski, Horst ^a   Krause, Robert ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CASPOFUNGIN; COTRIMOXAZOLE; FLUCONAZOLE; ITRACONAZOLE; PAROMOMYCIN; VANCOMYCIN; VORICONAZOLE;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG EFFICACY; FEMALE; FUNGAL COLONIZATION; FUNGUS ISOLATION; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; THRUSH; WHOLE BODY RADIATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; CARRIER STATE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; INTESTINES; MALE; MIDDLE AGED; MOUTH; PAROMOMYCIN; PREVALENCE; RISK FACTORS; VANCOMYCIN;

EID: 46349085768     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/588827     Document Type: Article

References (12)

1. Marr KA, Seidel K, White TC, Bowden RA. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181:309-16.
2. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326:845-51.
3. Blijlevens NM, Donnelly JP, de Pauw BE. Impaired gut function as risk factor for invasive candidiasis in neutropenic patients. Br J Haematol 2002; 117:259-64.
4. Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin Infect Dis 2001; 33:1959-67.
5. Martino P, Girmenia C, Micozzi A, De Bernardis F, Boccanera M, Cassone A. Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients. Eur J Clin Microbiol Infect Dis 1994; 13:797-804.
6. Krause R, Schwab E, Bachhiesl D, et al. Role of Candida in antibiotic-associated diarrhea. J Infect Dis 2001; 184:1065-9.
7. Botterel F, Desterke C, Costa C, Bretagne S. Analysis of microsatellite markers of Candida albicans used for rapid typing. J Clin Microbiol 2001; 39:4076-81.
8. Tollemar J, Gross N, Dolgiras N, Jarstrand C, Ringden O, Hammarstrom L. Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients. Bone Marrow Transplant 1999; 23:283-90.
9. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20:115-25.
10. Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990; 28:2733-8.
11. Trenschel R, Peceny R, Runde V, et al. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination. Bone Marrow Transplant 2000; 26:993-7.
12. Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study - Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45:1161-70.